Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corp (NQ: QTRX )

14.20 +0.35 (+2.53%)
Streaming Delayed Price Updated: 10:36 AM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corp

< Previous 1 2 3 4 5 6 7 Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Recap: Quanterix Q1 Earnings
Via Benzinga
Quanterix Releases Operating Results for First Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix’s First Quarter 2023 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
Quanterix's Return On Capital Employed Insights
Via Benzinga
Preview: Quanterix's Earnings
Via Benzinga
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in Barclays Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
From Quanterix Corporation
Via Business Wire
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Quanterix Announces Appointment of Brian Blaser to Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
From Quanterix Corporation
Via Business Wire
Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Quanterix Corporation Releases Operating Results for Third Quarter 2022
From Quanterix Corporation
Via Business Wire
Earnings Preview For Quanterix
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Quanterix will... 
Via Benzinga
Quanterix’ Third Quarter 2022 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
New Acquisition Adds To Thermo Fisher's Specialty Dx Portfolio, Analyst Says
Via Benzinga
Top Small-Cap Stocks: Trading Opportunities For Next Week - Sunday, Oct. 16
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some small-cap stock opportunities... 
Via Talk Markets
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
Top Medical Specialties Stocks: Trading Opportunities For Next Week - Sunday, Oct. 2
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some medical stock opportunities... 
Via Talk Markets
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.